Radioimmunotherapy with a 64Cu-labeled monoclonal antibody: a comparison with 67Cu.
67Cu (t1/2 = 62 h) has demonstrated potential as a radionuclide for radioimmunotherapy, but limited availability severely restricts its widespread use. 64Cu (t1/2 = 12.8 h) has been shown to have comparable effectiveness in vitro and in vivo. The present study was undertaken to examine the therapeut...
Na minha lista:
| Publicado no: | Proc Natl Acad Sci U S A |
|---|---|
| Principais autores: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
National Academy of Sciences
1996
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC39110/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8692901/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.93.13.6814 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|